Combination Therapies for Melanoma: A New Standard of Care?

ABSTRACT: Recent data have demonstrated improved survival with targeted and immune therapies in patients with advanced melanoma, leading to much excitement amongst the oncology community and the widespread use of these drugs in combination regimens. However, the place of these combination therapies in the treatment of advanced melanoma remains to be fully determined. In this perspectives article, we critically review the available data and outline the rationale for these combinations being adopted as the standard of care for patients with advanced melanoma in the future.

SUBMITTER: Smalley KS 

PROVIDER: S-EPMC4805442 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature